CTRI/2020/08/027054尚未招募未知
Study of the excess cost associated with drug wastage due to limited vial size options of the intravenous drugs for anti-cancer treatment, among patients receiving such treatment at Tata Memorial Hospital - CADWIACT
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adult cancer patients
- •The patients advised and receiving any of the following 62 chemotherapy protocols will be included in the study.
- •Paclitaxel+-trastuzumab
- •Gemcitabine+carboplatin
- •Carboplatin+paclitaxel+/-Bevacizumab
- •Liposomal doxorubin
- •TCH(Docetaxel,carboplatin,trastuzumab)
- •SA Dactinomycin
- •SA Methotrexate
- •Cap-Irinotecan
- •SA Docetaxel
- •Panitumumab
- •Trastuzumab
- •Ramucirumab
- •Cape-Mitomycin
- •Gem-Oxaliplatin
- •Gem+cisplatin
- •Gem+nab paclitaxel
- •Pemetrexed+Cisplatin
- •Pemetrexed+Carboplatin
- •Pemetrexed-carboplatin+/- pembrolizumab
- •Gemcitabine+carboplatin
- •Paclitaxel+carboplatin
- •Geftinib+bevacizumab
- •Cisplatin+etoposide
- •Carboplatin+etoposide
- •SA Irinotecan
- •SA Gemcitabine
- •SA Paclitaxel
- •SA Docetaxel
- •Gemcitabine+cisplatin
- •Gemcitabine+carboplatin
- •Adult Hematology
- •Bendamustine-rituximab
排除标准
- •patients aged < 18 years
研究者
相似试验
尚未招募
4 期
A clinical trial to study adverse drug reactions , and direct and indirect cost due to ADR in a psychiatry department for one year duratioCTRI/2016/10/007375Government Medical College Bhavnagar200
尚未招募
不适用
Direct Medical Costs Associated With Negative Diagnosis of IBS.Irritable Bowel SyndromeNCT05144594Region Örebro County3,000
尚未招募
Unknown
Cancer Chemotherapy Drug WastageCTRI/2024/06/069297Mohamed Siddiq Muhammad Basheer
尚未招募
不适用
Health economic outcomes of the medication reconciliation service in the pediatric sector of a high-complexity public hospital: A Randomized Clinical TrialPneumonia due to unspecified microorganismAcute bronchiolitisRBR-25dnqskFundação Universidade Federal de Sergipe
尚未招募
不适用
Study on cancer patients in PMJAY Ayushman Bharath Yojana schemeCTRI/2021/11/038309I